Title: Targeting of interleukin-13 receptor (IL-13R) a2 expressing pancreatic cancer by a novel hybrid lytic peptide drug

Funder
HEFCW,Welsh Government

Principal Investigator

Project Details
Start date: 01/10/2016
End date: 15/11/2018

Last updated on 2021-16-01 at 06:02